Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
109 Leser
Artikel bewerten:
(0)

NOKIA: Nokia Technologies to collaborate with Helsinki University Hospital and University of Helsinki to create innovative solutions for outpatient care

The collaboration signals Nokia Technologies' intent to enter clinical healthcare space

21 June 2016

Espoo, Finland - Nokia Technologies today announced a collaboration with HUS/Helsinki University Hospital and University of Helsinki, Faculty of Medicine to create innovative solutions for outpatient care and to foster mutual research and development. The first project under this collaboration will launch this quarter, with Nokia Technologies and HUS working to develop remote patient monitoring solutions. The collaboration is a first for Nokia Technologies, reflecting the company's intent to enter the regulated healthcare space.

"Our vision is to empower people to make good decisions about their health by providing them and their physician with the critical information they need, when they need it," said Cédric Hutchings, Vice President of Digital Health at Nokia Technologies. "I'm excited about our collaboration with HUS as it will help us extend our span of care from everyday health and wellness devices to clinical solutions that help improve patient/physician interaction while informing our continued research and development in the clinical space."

The Department of Neurology at HUS is the largest neurology center in Finland focused on the diagnosis, treatment and rehabilitation of diseases of the nervous system or the brain, spinal cord, peripheral nervous system and muscles. With over 14,000 patients visiting Meilahti Hospital's Neurological Outpatient Clinic in Helsinki every year, the collaboration will enable input from HUS clinicians and patients to improve the quality and effectiveness of Nokia Technologies' remote patient monitoring solutions, all while driving meaningful patient outcomes.

"At HUS, we see tremendous value in collaborating with innovative companies like Nokia to help the development of research-based knowledge into technologies that can drive more effective, personalized care for our patients," said MD, PhD Nina Forss, Head of Department of Neurology. "The department of Neurology at HUS is acknowledged worldwide for providing the best acute stroke care in the world. This new collaboration reflects our continued commitment to excellence in research and improves the health and care of our patients at the later stage of the treatment chain."

Nokia Technologies completed the acquisition of Withings, a leader in the connected health revolution, on May 31. Established in 2008, Withings has introduced a range of award-winning products across the health spectrum including: activity trackers (Withings Pulse and Activité); Wi-Fi scale and health station (Body Cardio); Wireless Blood Pressure Monitor; security camera with air quality sensors (Withings Home); and an advanced sleep system (Withings Aura). Every piece of collected data comes to life in Withings applications where users can find coaching, motivation and insights to shape key aspects of their health.

About Nokia Technologies
Nokia Technologies is Nokia's advanced technology and licensing business. Formed in 2014, TECH builds upon our solid foundation of industry-leading licensing and technology R&D capabilities. By focusing on Digital Health, Digital Media, Brand Licensing and Patent Licensing, TECH is expanding the human possibilities of the ever-evolving world of technology. In 2015, Nokia Technologies launched OZO, the world's first virtual reality (VR) camera designed for professionals.

About HUCH Institute
The Clinical Research Institute HUCH Ltd. is responsible for the promotion of clinical pharmaceutical research and research administration of the Hospital District of Helsinki and Uusimaa and develops the operations of the central core facilities at Biomedicum Helsinki. The company also develops and offers services related to the commercialization of the results of medical research.

About HUS
HUS is a specialized healthcare provider characterized by high quality and good efficiency. The HUS is organized into Helsinki University Hospital and four regional hospitals. Apart from diagnosis and treatment of patients, the Hospital's services include education and research of high international standard in close collaboration with the University of Helsinki, Aalto University, and several medtech and pharma companies.

About the University of Helsinki, Faculty of Medicine
The University of Helsinki is an internationally oriented university focusing on excellence in research (including health and medical sciences) and education, development and commercialization of research-based knowledge and technologies thereby underpinning growth and development in the private sector and improved health and treatment of diseases in society.

Media Enquiries:
Nokia Technologies
Media Relations
Email: tech.press@nokia.com (mailto:tech.press@nokia.com)
Tel. +1 408 203 5906




This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NOKIA via Globenewswire

HUG#2021976
Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2016 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.